SCLX Scilex Holding Co
Nasdaq · SEC CIK 1820190 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $12.81M 1 sales by 1 insiders
- Filings on record
- 61 since 2022-11-15, latest 2026-07-07 21:25
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Scilex Holding Co | 10% | — | $12.81M |
| SCLX Stock Acquisition JV LLC | 10% | — | — |
Transactions 29
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-07 21:25 | 2026-07-03 | SCLX | SCLX Stock Acquisition JV LLC | 10% | J - Other | — | -500.0K | 958.3K | -34% | — | |
| M | 2025-12-30 | 2025-12-26+ | SCLX | Scilex Holding Co | 10% | S - Sale | $0.62 | -20.66M | 261.41M | -7% | -$12.81M |
| 2025-01-23 | 2025-01-21 | SCLX | SCLX Stock Acquisition JV LLC | 10% | J - Other | — | -3.25M | 51.04M | -6% | — | |
| 2025-01-17 | 2025-01-16 | SCLX | SCLX Stock Acquisition JV LLC | 10% | J - Other | — | -779.4K | 54.29M | -1% | — | |
| 2025-01-06 | 2025-01-02 | SCLX | SCLX Stock Acquisition JV LLC | 10% | J - Other | — | -5.00M | 55.07M | -8% | — | |
| 2024-12-18 | 2024-12-18 | SCLX | SHAH JAISIM | See Remarks, Dir | P - Purchase | $0.46 | +30.0K | 139.3K | +27% | +$13.8K | |
| 2024-10-31 | 2024-10-31 | SCLX | Ji Henry | Executive COB, Dir | P - Purchase | $0.94 | +8,888 | 320.2K | +3% | +$8,355 | |
| 2024-10-29 | 2024-10-29 | SCLX | SHAH JAISIM | See Remarks, Dir | P - Purchase | $0.99 | +32.0K | 109.3K | +41% | +$31.7K | |
| I | 2024-10-18 | 2024-10-17 | SCLX | Ji Henry | Executive COB, Dir | P - Purchase | $0.97 | +10.0K | 60.1K | +20% | +$9,700 |
| 2024-10-18 | 2024-10-18 | SCLX | Followwill Dorman | Dir | P - Purchase | $0.99 | +1,000 | 2,300 | +77% | +$990 | |
| 2024-10-18 | 2024-10-17 | SCLX | Wu Yue Alexander | Dir | P - Purchase | $0.95 | +20.0K | 25.0K | +400% | +$19.0K | |
| 2024-10-18 | 2024-10-17 | SCLX | Lemus David | Dir | P - Purchase | $0.9 | +2,000 | 2,000 | New | +$1,800 | |
| 2024-10-18 | 2024-10-18 | SCLX | Chun Jay | Dir | P - Purchase | $0.95 | +5,000 | 112.5K | +5% | +$4,750 | |
| 2024-10-17 | 2024-10-16 | SCLX | SHAH JAISIM | See Remarks, Dir | P - Purchase | $0.99 | +30.0K | 77.3K | +63% | +$29.7K | |
| 2024-10-17 | 2024-10-16 | SCLX | Ma Stephen Hoi | CFO | P - Purchase | $0.97 | +6,700 | 22.8K | +42% | +$6,499 | |
| D | 2024-06-26 | 2024-06-26 | SCLX | Followwill Dorman | Dir | M - OptEx | $1.37 | +1,000 | 1,300 | +333% | +$1,370 |
| D | 2024-06-20 | 2024-06-20 | SCLX | Ma Stephen Hoi | CFO | M - OptEx | $1.41 | +2,000 | 16.1K | +14% | +$2,820 |
| D | 2024-06-20 | 2024-06-20 | SCLX | SHAH JAISIM | See Remarks, Dir | M - OptEx | $1.73 | +14.0K | 47.3K | +42% | +$24.2K |
| D | 2024-06-20 | 2024-06-20 | SCLX | Wu Yue Alexander | Dir | M - OptEx | $1.41 | +5,000 | 5,000 | New | +$7,050 |
| D | 2024-06-20 | 2024-06-20 | SCLX | Chun Jay | Dir | M - OptEx | $1.41 | +5,000 | 107.5K | +5% | +$7,050 |
| D | 2024-06-18 | 2024-06-18 | SCLX | Ji Henry | Executive COB, Dir | M - OptEx | $1.41 | +6,000 | 311.3K | +2% | +$8,460 |
| D | 2024-06-14 | 2024-06-14 | SCLX | SHAH JAISIM | See Remarks, Dir | M - OptEx | $1.41 | +33.3K | 33.3K | New | +$47.0K |
| 2024-05-17 | 2024-05-17 | SCLX | Chun Jay | Dir | P - Purchase | $0.9 | +57.5K | 102.5K | +128% | +$51.8K | |
| 2024-05-17 | 2024-05-17 | SCLX | Ma Stephen Hoi | CFO | P - Purchase | $0.88 | +14.1K | 14.1K | New | +$12.4K | |
| I | 2024-05-17 | 2024-05-17 | SCLX | Ji Henry | Executive COB, Dir | P - Purchase | $0.88 | +50.0K | 50.1K | +71,429% | +$44.0K |
| MI | 2024-05-17 | 2024-05-16+ | SCLX | SHAH JAISIM | See Remarks, Dir | P - Purchase | $0.8725 | +140.0K | 98.9K | New | +$122.2K |
| D | 2023-09-25 | 2023-09-21 | SCLX | Sorrento Therapeutics, Inc. | 10% | S - Sale | — | -60.07M | 1.92M | -97% | — |
| I | 2023-03-20 | 2023-03-17 | SCLX | Ji Henry | Executive COB, Dir | J - Other | $8.60 | +2,730 | 2,730 | New | +$23.5K |
| 2023-01-23 | 2023-01-19 | SCLX | Sorrento Therapeutics, Inc. | 10% | J - Other | $0.00 | -73.74M | 61.99M | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations